BIOMAT Database Logo BIOMAT Database Logo

Design, synthesis and mechanism of action of novel 1,9-disubstituted β-carboline derivatives as antitumor agents. 2022

Fangrui Zhao, and Jingsheng Ao, and Feng Zeng, and Rihui Cao, and Xiangpan Li
Department of Oncology, Renmin Hospital of Wuhan University, 238 Jiefang Road, Wuchang 430072, PR China.

A range of novel 1,9-disubstituted β-carboline derivatives was designed, synthesized and evaluated as potential anticancer agents. The preliminary study suggested that compounds 6a, 6b, 6c, 6d, 6e, 6f, 6g, and 6h tested in this study exerted potent antiproliferative effects on ten selected human tumor cell lines, with compound 6e being the most effective antiproliferative agent against the BGC-823, A375 and HT-29 cell lines, with IC50 values of 23.9, 9.3, and 3.6 µM, respectively. In addition, the antitumor capability of compound 6e was also evaluated in vivo, which demonstrated that compound 6e distinctly inhibited colorectal tumor growth in syngeneic BALB/c mice. Further research into the fundamental mechanism revealed that compound 6e inhibited colorectal cancer growth through the ATG5 (autophagy-related-5)/ATG7 (autophagy-related-7)-dependent autophagy pathway. This research can contribute to further clinical application of β-carboline derivatives as new antitumor drugs.

UI MeSH Term Description Entries
D002243 Carbolines A group of pyrido-indole compounds. Included are any points of fusion of pyridine with the five-membered ring of indole and any derivatives of these compounds. These are similar to CARBAZOLES which are benzo-indoles. Carboline,Pyrido(4,3-b)Indole,Beta-Carbolines,Pyrido(4,3-b)Indoles,Beta Carbolines
D004354 Drug Screening Assays, Antitumor Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. Anticancer Drug Sensitivity Tests,Antitumor Drug Screens,Cancer Drug Tests,Drug Screening Tests, Tumor-Specific,Dye Exclusion Assays, Antitumor,Anti-Cancer Drug Screens,Antitumor Drug Screening Assays,Tumor-Specific Drug Screening Tests,Anti Cancer Drug Screens,Anti-Cancer Drug Screen,Antitumor Drug Screen,Cancer Drug Test,Drug Screen, Anti-Cancer,Drug Screen, Antitumor,Drug Screening Tests, Tumor Specific,Drug Screens, Anti-Cancer,Drug Screens, Antitumor,Drug Test, Cancer,Drug Tests, Cancer,Screen, Anti-Cancer Drug,Screen, Antitumor Drug,Screens, Anti-Cancer Drug,Screens, Antitumor Drug,Test, Cancer Drug,Tests, Cancer Drug,Tumor Specific Drug Screening Tests
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines
D049109 Cell Proliferation All of the processes involved in increasing CELL NUMBER including CELL DIVISION. Cell Growth in Number,Cellular Proliferation,Cell Multiplication,Cell Number Growth,Growth, Cell Number,Multiplication, Cell,Number Growth, Cell,Proliferation, Cell,Proliferation, Cellular
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus

Related Publications

Fangrui Zhao, and Jingsheng Ao, and Feng Zeng, and Rihui Cao, and Xiangpan Li
Design and Synthesis of Biotinylated Bivalent Carboline Derivatives as Potent Antitumor Agents.
September 2020, The Journal of organic chemistry,
Fangrui Zhao, and Jingsheng Ao, and Feng Zeng, and Rihui Cao, and Xiangpan Li
Design, synthesis, and evaluation of a novel class of 2,3-disubstituted-tetrahydro-β-carboline derivatives.
June 2012, Bioorganic & medicinal chemistry letters,
Fangrui Zhao, and Jingsheng Ao, and Feng Zeng, and Rihui Cao, and Xiangpan Li
Design, synthesis and 3D-QSAR of beta-carboline derivatives as potent antitumor agents.
June 2010, European journal of medicinal chemistry,
Fangrui Zhao, and Jingsheng Ao, and Feng Zeng, and Rihui Cao, and Xiangpan Li
Design and synthesis of some β-carboline derivatives as multi-target anticancer agents.
December 2018, Future medicinal chemistry,
Fangrui Zhao, and Jingsheng Ao, and Feng Zeng, and Rihui Cao, and Xiangpan Li
Design of beta-carboline derivatives as DNA-targeting antitumor agents.
October 2006, European journal of medicinal chemistry,
Fangrui Zhao, and Jingsheng Ao, and Feng Zeng, and Rihui Cao, and Xiangpan Li
Design, synthesis, and structure-activity relationships of novel 6,7-disubstituted-4-phenoxyquinoline derivatives as potential antitumor agents.
November 2013, European journal of medicinal chemistry,
Fangrui Zhao, and Jingsheng Ao, and Feng Zeng, and Rihui Cao, and Xiangpan Li
Design and synthesis of β-carboline and combretastatin derivatives as anti-neutrophilic inflammatory agents.
June 2021, Bioorganic chemistry,
Fangrui Zhao, and Jingsheng Ao, and Feng Zeng, and Rihui Cao, and Xiangpan Li
Synthesis and structure-activity relationships of asymmetric dimeric β-carboline derivatives as potential antitumor agents.
March 2018, European journal of medicinal chemistry,
Fangrui Zhao, and Jingsheng Ao, and Feng Zeng, and Rihui Cao, and Xiangpan Li
Structural simplification of evodiamine: Discovery of novel tetrahydro-β-carboline derivatives as potent antitumor agents.
May 2021, Bioorganic & medicinal chemistry letters,
Fangrui Zhao, and Jingsheng Ao, and Feng Zeng, and Rihui Cao, and Xiangpan Li
Synthesis, biological activity and mechanism of action of novel allosecurinine derivatives as potential antitumor agents.
March 2023, Bioorganic & medicinal chemistry,
Copied contents to your clipboard!